BioReliance

A U.S. and Canada channel. MilliporeSigma's BioReliance® services is a global offering of biologics safety testing and product characterization

[BioReliance @BioReliance]

Adenoviral vector products require RCA testing, which can be a bottleneck for lot release. Our solution? Join this webinar to learn how a new rapid RCA assay in development can help expedite release testing. Register now here, https://t.co/HBzaht6TkS

[BioReliance @BioReliance]

We love when math tells the story. Trust our expert partners to perform your IND and BLA-enabling studies. It’s not too late to book for early 2022! https://t.co/qoAwOIJILj #bioreliance #viralclearance

[R&D 100 Awards @RD100Awards]

Congrats to @MilliporeSigma for being a winner in the Analytical/Test category for its Blazar™ Platform. MilliporeSigma’s innovative Blazar™ platform reduces turn-around-time from up to 63 days to ten days, while testing for 25 additional and emerging viral risks. #RD100

[BioReliance @BioReliance]

We’re honored to be the Interphex Awards 2020 Editor’s Choice recipient for the MilliporeSigma BioReliance® Blazar™ Platform. Congratulations to our team of innovators! #INTERPHEX #Bioprocessing #pharma #bio #PharmaceuticalProcessing

[BioReliance @BioReliance]

The COVID-19 pandemic has highlighted concerns of animal virus contamination of raw materials. Dr. Danny Galbraith shares insights to protect your process. #COVID19

[BioReliance @BioReliance]

Detecting the next permutations of COVID-19. Dr. Danny Galbraith discusses methods to predict virus mutations and recombination. . #COVID19 #MilliporeSigma #Biopharma

[BioReliance @BioReliance]

We’re engaging the biopharma community to prioritize biosafety testing. Just as we did during Zika, SARS, and Ebola outbreaks, we’re here to support vaccine and therapeutic developers & mfrs. Contact us https://t.co/n1fqiFgyRG @MilliporeSigma #covid19 #biopharma #vaccines #DCVMN

[BioReliance @BioReliance]

We’re here to support vaccine and therapeutic developers & mfrs to deliver therapies. Our facilities are operating and we’re prioritizing biosafety testing. Contact us. https://t.co/DtvLs7JxHe @MilliporeSigma #covid19 #biopharma #vaccines #DCVMN

[BioReliance @BioReliance]

Planning your trip to Society of Toxicology? Meet us at booth #631 and don't miss these powerful poster presentations. #2020sot https://t.co/XleaVc3Nod

[BioReliance @BioReliance]

We've got big news at SOT in Anaheim this year. Find out at booth #631. #2020sot https://t.co/KrE1vQiRpm

[BioReliance @BioReliance]

What if you have a positive in vitro assay? Don't panic. Our study directors are @ booth 631 at Society of Toxicology. #2020sot https://t.co/QOYto0vXbG

[BioReliance @BioReliance]

Join us at #ACTOX2019 as we tackle the tough questions at booth 304. Nov 20th Dr. Kulkarni presents on GeneTox Assays for Impurities Testing https://t.co/iuO8WHzeta

[BioReliance @BioReliance]

Join us at @ESGCT in Barcelona this week as Sarah Sheridan and Eva Fong present Rapid Biosafety Test Methods & Lentivirus Production in Suspension. #esgct19 #MilliporeSigma #bioreliance #genetherapy

[BioReliance @BioReliance]

MilliporeSigma launches CAN FlowScreen services for detection of multiple biomarkers in a single assay:https://t.co/GEzFcvTXWU

[BioReliance @BioReliance]

Register for Dr. Wisher’s Reg Guidance & Advice on the QC of Adv. Therapy Medicinal Products Workshop, 10/19 @ESGCT https://t.co/GFhv4XZydt

[BioReliance @BioReliance]

Marian McKee of @BioReliance talks to @BioPharmIntl about how new therapies are challenging #microbiology testing: https://t.co/X08YFP46kk

[BioReliance @BioReliance]

Looking forward to a productive 2 days of discussions on viral safety and raw materials. #viralsafety

[BioReliance @BioReliance]

Doug Chambers describes what makes a good #dataintegrity strategy, from training to implementation, in @ADCReview: https://t.co/n57rXtdqMu

[BioReliance @BioReliance]

Martha Rook, Head of Novel Therapies, & @PharmaProEditor on syncing science, tech & mfg: https://t.co/YeaTNNO4du #genetherapy #singleuse

[BioReliance @BioReliance]

Our team is about to board the plane to #Shanghai for the 5th Annual Cell Line Development & Engineering Asia! https://t.co/htXRCQUxsT